Table of contents
June 2005 Vol 5 No 6
In this issue
p413 | doi:10.1038/nrc1646
Research Highlights
Drug discovery: Small is beautiful
p415 | doi:10.1038/nrc1636
Cell cycle: Checking in
p416 | doi:10.1038/nrc1639
In the news
Cheerful treatment
p416 | doi:10.1038/nrc1641
Metastasis: Tipping the balance
p417 | doi:10.1038/nrc1634
In brief
Angiogenesis | Cancer Vaccines | Tumorigenesis | Therapeutics
p417 | doi:10.1038/nrc1640
Therapeutics: Off-target efficacy
p418 | doi:10.1038/nrc1638
Early detection: Screen test for the stars
p418 | doi:10.1038/nrc1642
Diagnosis: Skin deep?
p419 | doi:10.1038/nrc1637
Therapeutics: Precarious preconceptions
p420 | doi:10.1038/nrc1643
Early detection: Split prediction
p420 | doi:10.1038/nrc1644
Therapeutics: Cetuximab constricts conformational contortionist
p421 | doi:10.1038/nrc1635
Trial Watch
20-year outcomes
p421 | doi:10.1038/nrc1645
Reviews
Disrupting tumour blood vessels
Gillian M. Tozer, Chryso Kanthou & Bruce C. Baguley
p423 | doi:10.1038/nrc1628
Tumour vascular targeting
Dario Neri & Roy Bicknell
p436 | doi:10.1038/nrc1627
Pharmacokinetic variability of anticancer agents
Samir D. Undevia, Gonzalo Gomez-Abuin & Mark J. Ratain
p447 | doi:10.1038/nrc1629
Immunotherapy for pancreatic cancer — science driving clinical progress
Dan Laheru & Elizabeth M. Jaffee
p459 | doi:10.1038/nrc1630
Antisense therapy for cancer
Martin E. Gleave & Brett P. Monia
p468 | doi:10.1038/nrc1631
Perspectives
Opinion
Childhood solid tumours: a developmental disorder
Paul J. Scotting, David A. Walker & Giorgio Perilongo
p481 | doi:10.1038/nrc1633
Science and society
The Nikolas Symposia and histiocytosis
Peter C. L. Beverley, R. Maarten Egeler, Robert J. Arceci & Jon Pritchard
p488 | doi:10.1038/nrc1632
